Herpes Zoster Ophthalmicus clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Zoster Eye Disease Study

    open to eligible people ages 18 years and up

    This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.

    San Francisco, California and other locations

Our lead scientists for Herpes Zoster Ophthalmicus research studies include .

Last updated: